Business Standard

Zydus Life hits new peak; m-cap hits Rs 1 trn as stock up 60% in 3 months

The stock was quoting higher for a fifth straight trading day and has rallied 10 per cent during the period

Cadila Healthcare changes name to Zydus Lifesciences Limited
Premium

Deepak Korgaonkar Mumbai

Listen to This Article

Shares of Zydus Lifesciences hit a new high of Rs 1,015.70, surging nearly 4 per cent on the BSE in Monday's intraday trade, in an otherwise weak market, after the company said it has received the Establishment Inspection Report (EIR) report from the US drug regulator for its Ahmedabad facility.

Zydus Lifesciences, in an exchange filing, said the company has received the EIR report from the United States Food and Drug Administration (USFDA) for the inspection conducted at the API (active pharmaceutical ingredient) at Ahmedabad facility. An EIR means closure of inspection.

The company had earlier received a Post Application Action Letter

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Mar 11 2024 | 1:30 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com